VizChitra 2025: India's first community-driven Data Visualization conference

Abstract

In today’s data-rich biopharmaceutical landscape, visualization helps teams solve complex problems, simplify insights, and anticipate future outcomes. This talk explores how Lilly is applying data visualization across the R&D pipeline, from early discovery through clinical development, regulatory engagement, and beyond.

Key takeaways

We will discuss the challenges of redesigning clinical study results to meet the diverse needs of stakeholders, the limitations of static graphics, and the increasing demand for custom, interactive tools that support multidimensional data exploration. As AI and machine learning become central to drug discovery, we will envision the role of visualization will play in interpreting model outputs, ensuring transparency, and fostering trust. Finally, we’ll explore how generative AI will empower non-experts to create domain-relevant visualizations, unlocking new potential for efficiency and scale.

Audience

This talk is especially relevant for consultants, designers, and engineers working with biopharmaceutical organizations, offering practical insights into the evolving demands and opportunities of data visualization in the field.

Speaker

This talk will be presented by Aditeya Pandey, Senior Advisor, Head of Visual Analytics Hub, Eli Lilly and Company